Hunter Colorectal Research, Private Medical Suites, 26 Lookout Road, New Lambton, NSW, 2305, Australia.
Tech Coloproctol. 2011 Sep;15(3):301-11. doi: 10.1007/s10151-011-0711-7. Epub 2011 Jul 9.
Aim of the study was to assess adequacy of Colorectal Surgical Society of Australia and New Zealand (CSSANZ) endorectal ultrasound (ERUS) training and whether a subsequent learning curve exists.
A prospective audit of ERUS for staging rectal cancer by a single surgeon from commencement of consultant practice was performed. Data were recorded in a prospectively maintained database. The audit commenced on completion of CSSANZ training. T- and N-stage were assessed clinically, then by ERUS prior to treatment and finally by histology over 8 years.
The results were compared over three time periods: the first a single year, then two three-year periods. Two hundred and seventy-two patients were examined. Two hundred and thirty-three were assessable for T-stage (13 no tumour excision, 26 long course pre-operative radiotherapy) and 142 for N-stage (74 endoanal excision, 17 proximal mesorectum un-assessable). Overall accuracy was 82% for T-stage and 73% for N-stage. Accuracy for T- and N-staging did not change significantly over the three time periods (T: 82.1, 82.3, 81.6%, P = 0.14; N: 83.3, 67.9, 74.2%, P = 0.31). The utility of ERUS was demonstrated by clinical assessment not being possible in 32% of cases and where the two modalities disagreed was correct 82% of the time.
Endorectal ultrasound rectal cancer staging is accurate for T-stage. Competency in ERUS can be achieved in the CSSANZ fellowship and accuracy does not improve with further experience. An ERUS accreditation scheme should be established for future trainees.
本研究旨在评估澳大利亚和新西兰结直肠外科学会(CSSANZ)腔内超声(ERUS)培训的充分性,以及是否存在后续的学习曲线。
对一名顾问医生从开始执业时起进行直肠肿瘤腔内超声分期的前瞻性审核。数据记录在一个前瞻性维护的数据库中。审核在完成 CSSANZ 培训后开始。在治疗前,通过临床、ERUS 对 T 期和 N 期进行评估,然后通过组织学评估,共进行了 8 年。
将结果在三个时间段进行比较:第一年为一个时间段,然后是两个三年期。共检查了 272 例患者。233 例可评估 T 期(13 例无肿瘤切除,26 例长程术前放疗),142 例可评估 N 期(74 例经肛门切除,17 例近端直肠系膜无法评估)。T 期的总体准确率为 82%,N 期的准确率为 73%。在三个时间段内,T 期和 N 期的分期准确率没有显著变化(T:82.1%、82.3%、81.6%,P=0.14;N:83.3%、67.9%、74.2%,P=0.31)。ERUS 的实用性通过以下事实得到证明:在 32%的病例中无法进行临床评估,而在两种方法不一致的情况下,82%的时间是正确的。
腔内超声直肠肿瘤分期对 T 期准确。在 CSSANZ 研究员培训中可以达到 ERUS 的能力,并且经验的增加不会提高准确性。应该为未来的受训者建立一个 ERUS 认证计划。